The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

Catal­ent amps up plans to man­u­fac­ture J&J's Covid-19 vac­cine, adding vial fill­ing line in Italy

5 years ago

Covid-19 man­u­fac­tur­ing roundup: Catal­ent, As­traZeneca de­fend vac­cine batch qual­i­ty in safe­ty row — FT; US buys more Covid-19 an­ti­body sup­plies

5 years ago
Coronavirus

Mer­ck KGaA adds 350 work­ers at French site to build ca­pac­i­ty for 's­in­gle-use' tech for Covid-19 vac­cines, ther­a­pies

5 years ago
Outsourcing

Pfiz­er lays down its hand on Chi­nese biosims, of­fload­ing its 3-year-old plant to WuXi Bi­o­log­ics as com­pe­ti­tion grows

5 years ago

El­e­vate­Bio adds an­oth­er $525M to its war chest as it looks to build on next-gen man­u­fac­tur­ing 'base­cam­p'

5 years ago
Financing
Cell/Gene Tx

Ani Phar­ma picks up gener­ic play­er for a cool $210M, tur­bocharg­ing its man­u­fac­tur­ing and R&D wings

5 years ago
Outsourcing

Covid-19 man­u­fac­tur­ing roundup: Biden dou­bles down on vac­ci­na­tion plan with 100M-dose or­der; BioN­Tech, Pfiz­er ready to in­crease man­u­fac­tur­ing; J&J ex­pe­ri­ences de­liv­ery woes

5 years ago
Coronavirus

Re­call re­port: BRP Phar­ma pulls 47 bot­tles of gener­ic di­uret­ic spirono­lac­tone af­ter mix­ing dif­fer­ent strength pills

5 years ago
Pharma
FDA+

Syn­thet­ic DNA play­er Touch­light scores $60M round to more than triple man­u­fac­tur­ing ca­pac­i­ty as mR­NA gets hot

5 years ago
Financing

Ther­mo Fish­er will drop a whop­ping $600M in­to its man­u­fac­tur­ing sup­ply chain as Covid-19 work ramps up

5 years ago
Outsourcing

Eli Lil­ly pro­motes Edgar­do Her­nan­dez to head its man­u­fac­tur­ing op­er­a­tions as 19-year vet O'Neill hits the ex­it

5 years ago
People

FDA in­spec­tion back­log tops 1,000 — and could last for years — as House hear­ing rais­es se­ri­ous con­cerns

5 years ago
FDA+

Mod­er­na finds a con­tract man­u­fac­tur­ing part­ner to scale up vac­cine sup­ply

5 years ago
R&D

Covid vac­cine roundup: US vac­cine sup­plies grow, but ex­perts warn of po­ten­tial hic­cups in sup­ply chain; Emer­gent touts grow­ing Covid vac­cine ca­pac­i­ty

5 years ago

Pfiz­er's trou­ble-prone McPher­son plant — now ramp­ing up vac­cine sup­plies — was cit­ed for con­tin­u­ing vi­o­la­tions in ear­ly 2020

5 years ago

Ab­b­Vie of­floads UK site for $119M in sale to Chi­nese cell and gene ther­a­py play­er Phar­maron

5 years ago
Outsourcing
Cell/Gene Tx

No­var­tis pairs up with Cure­Vac to help dri­ve Covid-19 shot pro­duc­tion but may miss the show in the US, EU

5 years ago
Coronavirus

In the lat­est big in­vest­ment in gene ther­a­py man­u­fac­tur­ing, Bio­gen com­mits $200M to a ma­jor new fa­cil­i­ty in NC

5 years ago
Cell/Gene Tx

Swiss CD­MO Celonic finds a home at No­var­tis' Stein hub, plans to add 250 new jobs cen­tered on next-gen drugs

5 years ago
Outsourcing
Cell/Gene Tx

With stars aligned and cash in re­serve, Bob Nelsen's Re­silience plans a makeover at 2 new fa­cil­i­ty ad­di­tions to its drug man­u­fac­tur­ing up­start

5 years ago

Af­ter bail­ing on Covid-19 vac­cines, Mer­ck will team up with J&J to pro­duce its shot as part of un­usu­al Big Phar­ma pact

5 years ago
Coronavirus

A 'love sto­ry': WuXi AppTec wraps UK-based CRO in­to its cell and gene ther­a­py unit

5 years ago
Deals
Outsourcing

Avid Bioser­vices, with re­cent IPO and Covid-19 part­ner­ship in hand, launch­es 2nd phase of fa­cil­i­ty ex­pan­sion

5 years ago
Outsourcing

Biden wants a re­view of the API sup­ply chain. Will that par­lay in­to an ef­fort to 'on­shore' drug man­u­fac­tur­ing?

5 years ago
Outsourcing
First page Previous page 74757677787980 Next page Last page
A service from the Financial Times